Suppr超能文献

大鼠肝癌细胞中沉默的内源性胆固醇7-α-羟化酶基因的激活:一个对25-羟胆固醇具有抗性的新互补群。

Activation of the silent endogenous cholesterol-7-alpha-hydroxylase gene in rat hepatoma cells: a new complementation group having resistance to 25-hydroxycholesterol.

作者信息

Leighton J K, Dueland S, Straka M S, Trawick J, Davis R A

机构信息

Atherosclerosis and Hepatobiliary Research Center, University of Colorado Health Sciences Center, Denver 80262.

出版信息

Mol Cell Biol. 1991 Apr;11(4):2049-56. doi: 10.1128/mcb.11.4.2049-2056.1991.

Abstract

The oxysterol 25-hydroxycholesterol acts both as a regulatory sterol determining the expression of genes governed by sterol regulatory elements and as a substrate for 7-alpha-hydroxylase, the first and rate-limiting enzyme in the bile acid synthetic pathway. Most wild-type nonhepatic cells are killed by the cytotoxic action of 25-hydroxycholesterol. In contrast, liver cells, which express 7-alpha-hydroxylase activity, are resistant to killing by 25-hydroxycholesterol. We examined the possibility that selection for resistance to 25-hydroxycholesterol might lead to the derivation of a cell line expressing 7-alpha-hydroxylase. A rat hepatoma cell line (7-alpha-hydroxylase minus) was transfected with human DNA and screened for resistance to 25-hydroxycholesterol. Although parental hepatoma cells were all killed within a week, a 25-hydroxycholesterol-resistant cell line (L35 cells) which showed stable expression of 7-alpha-hydroxylase activity and mRNA was obtained. These cells exhibited normal inhibition of cholesterol biosynthesis by 25-hydroxycholesterol. Blocking 7-alpha-hydroxylase activity with ketoconazole also blocked the resistance of L35 cells to 25-hydroxycholesterol. Isolation of microsomes from these cells showed levels of 7-alpha-hydroxylase activity (22.9 pmol/min/mg of protein) that were comparable to the activity (33.2 pmol/min/mg) of microsomes isolated from the livers of rats killed during the high point of the diurnal cycle. Parental cells had no detectable activity. These data show a new complementation group for 25-hydroxycholesterol resistance: expression of 7-alpha-hydroxylase. Dexamethasone increased both the activity and the cellular content of mRNA coding for 7-alpha-hydroxylase. Since dactinomycin blocked the ability of dexamethasone to induce mRNA, active transcription is required. Southern analysis of genomic DNA showed that L35 cells contain the rat (endogenous) gene but not the human gene. Furthermore, the RNA expressed by L35 cells is similar in size to rat RNA and is distinct from the human form of 7-alpha-hydroxylase. The combined data indicate that L35 cells are resistant to 25-hydroxycholesterol because they express 7-alpha-hydroxylase. The mechanism responsible involves activation of the endogenous (silent) gene of the parental rat hepatoma cell.

摘要

氧化甾醇25-羟基胆固醇既作为一种调节性甾醇,决定由甾醇调节元件控制的基因表达,又作为7-α-羟化酶的底物,该酶是胆汁酸合成途径中的首个限速酶。大多数野生型非肝细胞会被25-羟基胆固醇的细胞毒性作用杀死。相比之下,表达7-α-羟化酶活性的肝细胞对25-羟基胆固醇的杀伤具有抗性。我们研究了对25-羟基胆固醇产生抗性的选择是否可能导致衍生出一种表达7-α-羟化酶的细胞系。用人类DNA转染大鼠肝癌细胞系(缺乏7-α-羟化酶),并筛选对25-羟基胆固醇的抗性。虽然亲代肝癌细胞在一周内全部死亡,但获得了一种对25-羟基胆固醇具有抗性的细胞系(L35细胞),该细胞系显示出7-α-羟化酶活性和mRNA的稳定表达。这些细胞表现出25-羟基胆固醇对胆固醇生物合成的正常抑制作用。用酮康唑阻断7-α-羟化酶活性也阻断了L35细胞对25-羟基胆固醇的抗性。从这些细胞中分离微粒体显示7-α-羟化酶活性水平(22.9皮摩尔/分钟/毫克蛋白质)与从昼夜周期高峰期处死的大鼠肝脏中分离的微粒体活性(33.2皮摩尔/分钟/毫克)相当。亲代细胞没有可检测到的活性。这些数据显示了一个新的对25-羟基胆固醇抗性的互补组:7-α-羟化酶的表达。地塞米松增加了7-α-羟化酶的活性和编码该酶的mRNA的细胞含量。由于放线菌素D阻断了地塞米松诱导mRNA的能力,因此需要活跃的转录。对基因组DNA的Southern分析表明,L35细胞含有大鼠(内源性)基因,但不含有人类基因。此外,L35细胞表达的RNA大小与大鼠RNA相似,且与人类形式的7-α-羟化酶不同。综合数据表明,L35细胞对25-羟基胆固醇具有抗性是因为它们表达7-α-羟化酶。其机制涉及亲代大鼠肝癌细胞内源性(沉默)基因的激活。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7724/359892/afe1d23e0268/molcellb00138-0287-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验